Albuterol Sulfate
Product Images NDC 76519-1175

14 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 76519-1175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (76519 1175 Ppac Label)

Label (76519 1175 Ppac Label)
Label for ALBUTEROL SULFATE HFA (VENTOLIN) 90 mcg inhaler showing active ingredient and strength. The label includes NDC 76519-1175-00 and a quantity of 18 grams. It features manufacturing information with lot number AB00CD and an expiration date placeholder 00/00. The label advises use as directed by a physician and includes federal caution about prescription use. The label is from H.J. Harkins Company, Inc.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
Chemical structure diagram of albuterol sulfate, showing the molecular arrangement with hydroxyl groups, a benzene ring, and the sulfate salt component.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
Line graph depicting the mean percentage change from baseline over 6 hours. The chart compares three treatments: CFC 11/12-propelled albuterol (▲), Albuterol sulfate HFA (●), and HFA-134a placebo inhaler (■), each administered as 2 inhalations 4 times daily to separate groups (n=99, 101, and 97 respectively). The vertical axis shows mean % change, and the horizontal axis represents time in hours.*
FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
A line graph depicting the mean percentage change from baseline over time in hours for three groups: CFC 11/12-propelled albuterol (2 inhalations, 4 times daily), Albuterol sulfate HFA (2 inhalations, 4 times daily), and HFA-134a placebo inhaler (2 inhalations, 4 times daily). The graph shows higher improvements for both albuterol groups compared to placebo, with values decreasing over 6 hours.*
FDA Label Image

Figure A (Figurea)

Figure A (Figurea)
An illustration diagram of an Albuterol Sulfate HFA inhaler labeled with parts including the metal canister, counter, strap, plastic actuator, mouthpiece, and cap. This diagram visually identifies the main components of the inhaler device.*
FDA Label Image

Figure B (Figureb)

Figure B (Figureb)
Illustration showing a close-up view of the actuator and mouthpiece of an ALBUTEROL SULFATE HFA inhaler. The image highlights a label marked '204' on the inhaler canister. The background is shaded light blue.*
FDA Label Image

Figure C (Figurec)

Figure C (Figurec)
An instructional illustration showing a person holding an ALBUTEROL SULFATE HFA inhaler. The image demonstrates the proper hand position with a finger pressing down on the canister to release a dose, indicated by an arrow pointing downward and a visible spray coming out of the inhaler mouthpiece.*
FDA Label Image

Figure D (Figured)

Figure D (Figured)
An instructional diagram showing a close-up view of an inhaler device's mouthpiece and dose counter displaying the number 200. The image highlights the part of the inhaler used for medication delivery, likely related to ALBUTEROL SULFATE HFA.*
FDA Label Image

Figure E (Figuree)

Figure E (Figuree)
An instructional illustration showing the proper 'Mouthpiece-Down Position' for holding an ALBUTEROL SULFATE HFA inhaler. The diagram labels the mouthpiece, strap, and cap parts of the inhaler, with a hand demonstrating correct positioning.*
FDA Label Image

Figure F (Figuref)

Figure F (Figuref)
Illustration showing a person using an inhaler device by pushing down on the top while breathing in. The image includes an instruction to "Push down and breathe in." It illustrates proper inhaler use technique.*
FDA Label Image

Figure G (Figureg)

Figure G (Figureg)
An instructional illustration showing correct and incorrect use of an Albuterol Sulfate HFA inhaler. The upper image labeled 'Not Blocked' shows the inhaler releasing medication properly. The lower image labeled 'Blocked' shows the inhaler's mouthpiece obstructed, causing improper release.*
FDA Label Image

Figure H (Figureh)

Figure H (Figureh)
An instructional illustration showing a hand rinsing an inhaler canister under a running water faucet, with the inhaler disassembled to separate the canister from the plastic actuator.*
FDA Label Image

Figure I (Figurei)

Figure I (Figurei)
An instructional illustration showing a hand holding an Albuterol Sulfate HFA inhaler under running water from a faucet, demonstrating the cleaning of the inhaler mouthpiece. The background includes sink fixtures with handles.*
FDA Label Image

Figure J (Figurej)

Figure J (Figurej)
Illustration showing a nighttime view through a window with a crescent moon visible, above two images of an inhaler device: one fully assembled with a mouthpiece cover open, and one with the cover closed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.